Skip to main content
. 2020 Mar 16;2020:8138195. doi: 10.1155/2020/8138195

Table 1.

Randomized list of the administration sequences in each subgroup.

Subgroup A1 (n = 2) Subgroup A2 (n = 2) Subgroup A3 (n = 2) Subgroup A4 (n = 2) Subgroup A5 (n = 1) Subgroup A6 (n = 1) Subgroup A7 (n = 1) Subgroup A8 (n = 1)
Period 1 Glucose Starch + TZQ Maltodextrin + TZQ Sucrose + TZQ Maltose + TZQ Glucose + TZQ Glucose Glucose
Period 2 Glucose Glucose Starch + TZQ Maltodextrin + TZQ Sucrose + TZQ Maltose + TZQ Glucose + TZQ Glucose
Period 3 Glucose Glucose Glucose Starch + TZQ Maltodextrin + TZQ Sucrose + TZQ Maltose + TZQ Glucose + TZQ
Period 4 Glucose + TZQ Glucose Glucose Glucose Starch + TZQ Maltodextrin + TZQ Sucrose + TZQ Maltose + TZQ
Period 5 Maltose + TZQ Glucose + TZQ Glucose Glucose Glucose Starch + TZQ Maltodextrin + TZQ Sucrose + TZQ
Period 6 Sucrose + TZQ Maltose + TZQ Glucose + TZQ Glucose Glucose Glucose Starch + TZQ Maltodextrin + TZQ
Period 7 Maltodextrin + TZQ Sucrose + TZQ Maltose + TZQ Glucose + TZQ Glucose Glucose Glucose Starch + TZQ
Period 8 Starch + TZQ Maltodextrin + TZQ Sucrose + TZQ Maltose + TZQ Glucose + TZQ Glucose Glucose Glucose

The influences of 3-, 6-, and 9-tablet TZQ on the blood glucose levels were evaluated following the oral administration of the carbohydrates to subjects in the low-dose group, middle-dose group, and high-dose group, respectively.